CIBC World Market
PTCT icon

CIBC World Market’s PTC Therapeutics PTCT Stock Holding History

CIBC World Market’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-125,000
Closed -$3.64M – 1338
2024
Q1 		$3.64M Buy
+125,000
New +$3.5M 0.01% 525

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Market's PTCT Position: Q2 2024 in Review

CIBC World Market sold out of PTC Therapeutics (PTCT) in Q2 2024, closing a stake of 125,000 shares — an estimated $3.64M sold.

CIBC World Market first reported a position in PTCT in Q1 2024 and held it in 1 quarter. The position peaked at $3.64M in Q1 2024. 198 funds tracked by Wall St. Rank hold PTCT as of Q2 2024.

  • CIBC World Market reported no remaining PTC Therapeutics position as of Q2 2024 after selling out during the quarter.
  • CIBC World Market sold 125,000 PTC Therapeutics shares in Q2 2024, an estimated $3.64M.
  • CIBC World Market first reported a position in PTC Therapeutics in Q1 2024 and held it in 1 quarter.
  • CIBC World Market's PTC Therapeutics position peaked at $3.64M in Q1 2024.
  • 198 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2024.

Based on CIBC World Market's 13F filing for Q2 2024, filed 7 Aug 2024.